Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.
Unravelling Osteopenia in ICD-10: Accurate Coding and Clinical Implications for British Healthcare Professionals
December 5, 2025
No Comments
Osteopenia, characterized by reduced bone mineral density, serves as a critical precursor to osteoporosis and increases fracture risk, especially in postmenopausal women. Accurate ICD-10 coding of osteopenia, including specifying affected sites and menopausal status, is essential in the UK for effective patient management, public health monitoring, and resource allocation within the NHS. Challenges in coding arise due to incomplete records and unclear documentation. Studies indicate that factors like low body weight raise fracture risks among osteopenic patients, underscoring the need for precise coding and thorough clinical documentation. Enhancing screening and coding accuracy ensures timely interventions, improves bone health outcomes, and supports healthcare planning. Ongoing education on osteopenia ICD-10 coding is vital for clinicians and coders to optimize musculoskeletal care delivery in British healthcare.
